| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Wood Gavin (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Bought 39,000 shares
@ $0.2904, valued at
$11.3k
|
|
| 01/13/2022 |
4
| Wood Gavin (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,407,072 options to buy
@ $0
Granted 314,256 options to buy
@ $0 |
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Wood Gavin (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Bought 24,000 shares
@ $0.6896, valued at
$16.6k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2020 |
4
| Wood Gavin (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 2,500,000 options to buy
@ $0
Granted 565,000 options to buy
@ $0 |
|
| 04/01/2020 |
3
| Wood Gavin (CFO) has filed a Form 3 on Adaptimmune Therapeutics PLC |
| 04/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Wood Gavin (EVP, CFO) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 671 shares
@ $0
Granted 29,859 shares
@ $0 |
|
| 09/03/2013 |
4
| Wood Gavin (CFO) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Granted 25,000 shares
@ $0
Paid exercise price by delivering 158 shares
@ $5.57, valued at
$880.1
Granted 90,000 options to buy
@ $5.57, valued at
$501.3k
|
|
| 07/29/2013 |
4
| Wood Gavin (CFO) has filed a Form 4 on AFFYMETRIX INC|
Txns:
| Paid exercise price by delivering 158 shares
@ $3.8, valued at
$600.4 |
|
| 05/30/2013 |
3
| Wood Gavin (CFO) has filed a Form 3 on AFFYMETRIX INC |